Cargando…

Quantification and composition of pharmaceutical waste in New Zealand

This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanning, Sara M., Hua, Changji, Baroutian, Saeid, Burrell, Rob, Taylor, Matthew, Wright, L. James, Svirskis, Darren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085561/
https://www.ncbi.nlm.nih.gov/pubmed/35570848
http://dx.doi.org/10.1007/s10163-022-01410-z
_version_ 1784703847391821824
author Hanning, Sara M.
Hua, Changji
Baroutian, Saeid
Burrell, Rob
Taylor, Matthew
Wright, L. James
Svirskis, Darren
author_facet Hanning, Sara M.
Hua, Changji
Baroutian, Saeid
Burrell, Rob
Taylor, Matthew
Wright, L. James
Svirskis, Darren
author_sort Hanning, Sara M.
collection PubMed
description This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical waste collected from hospitals and pharmacies in Auckland increased by more than fourfold from 2016 to 2020. An audit of the types of pharmaceutical waste collected from community pharmacies revealed that the most common classes of drugs identified in this waste stream belonged to the nervous system, cardiovascular system and alimentary tract, and metabolism. Following examination of the contents of 12 pharmaceutical waste bins, 475 different pharmaceutical products were identified, highlighting the breadth of drugs in this waste stream. A range of dosage forms and hence materials were identified, which could present challenges for future waste treatment approaches. Hazardous drugs were identified including cytotoxic compounds, which should go into a separate waste stream for incineration. There is a need for similar data to be collected from multiple sites to fully appreciate the magnitude and composition of pharmaceutical waste. This will allow for the suitability of current practices for managing this hazardous waste stream to be evaluated.
format Online
Article
Text
id pubmed-9085561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-90855612022-05-10 Quantification and composition of pharmaceutical waste in New Zealand Hanning, Sara M. Hua, Changji Baroutian, Saeid Burrell, Rob Taylor, Matthew Wright, L. James Svirskis, Darren J Mater Cycles Waste Manag Regional Case Study This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical waste collected from hospitals and pharmacies in Auckland increased by more than fourfold from 2016 to 2020. An audit of the types of pharmaceutical waste collected from community pharmacies revealed that the most common classes of drugs identified in this waste stream belonged to the nervous system, cardiovascular system and alimentary tract, and metabolism. Following examination of the contents of 12 pharmaceutical waste bins, 475 different pharmaceutical products were identified, highlighting the breadth of drugs in this waste stream. A range of dosage forms and hence materials were identified, which could present challenges for future waste treatment approaches. Hazardous drugs were identified including cytotoxic compounds, which should go into a separate waste stream for incineration. There is a need for similar data to be collected from multiple sites to fully appreciate the magnitude and composition of pharmaceutical waste. This will allow for the suitability of current practices for managing this hazardous waste stream to be evaluated. Springer Japan 2022-05-10 2022 /pmc/articles/PMC9085561/ /pubmed/35570848 http://dx.doi.org/10.1007/s10163-022-01410-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Regional Case Study
Hanning, Sara M.
Hua, Changji
Baroutian, Saeid
Burrell, Rob
Taylor, Matthew
Wright, L. James
Svirskis, Darren
Quantification and composition of pharmaceutical waste in New Zealand
title Quantification and composition of pharmaceutical waste in New Zealand
title_full Quantification and composition of pharmaceutical waste in New Zealand
title_fullStr Quantification and composition of pharmaceutical waste in New Zealand
title_full_unstemmed Quantification and composition of pharmaceutical waste in New Zealand
title_short Quantification and composition of pharmaceutical waste in New Zealand
title_sort quantification and composition of pharmaceutical waste in new zealand
topic Regional Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085561/
https://www.ncbi.nlm.nih.gov/pubmed/35570848
http://dx.doi.org/10.1007/s10163-022-01410-z
work_keys_str_mv AT hanningsaram quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT huachangji quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT baroutiansaeid quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT burrellrob quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT taylormatthew quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT wrightljames quantificationandcompositionofpharmaceuticalwasteinnewzealand
AT svirskisdarren quantificationandcompositionofpharmaceuticalwasteinnewzealand